Marius, T. (2023). Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): A randomised, double-blind, placebo-controlled phase 3 trial. Springer.
Chicago Style CitationMarius, Trøseid. Efficacy and Safety of Baricitinib in Hospitalized Adults With Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-blind, Placebo-controlled Phase 3 Trial. Springer, 2023.
MLA CitationMarius, Trøseid. Efficacy and Safety of Baricitinib in Hospitalized Adults With Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-blind, Placebo-controlled Phase 3 Trial. Springer, 2023.
Warning: These citations may not always be 100% accurate.